Opioid cash grab: As federal funding dries up, states turn to settlement money

At a recent Nevada legislative committee hearing, lawmakers faced off with members of the governor’s administration over how to fill gaping holes in the state’s upcoming budget.

Pfizer gets an FDA win in hemophilia after a rough week

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 12, 2024

Graduate student admissions paused and cut back as universities react to Trump orders on research

Acceptances for biomedical graduate students and postdoctoral scholars are being cut back at some universities and medical centers across the country as many grapple with

February 19, 2025

BNT-325 by Duality Biologics (Shanghai) for Metastatic Ovarian Cancer: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

July 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.